C

Cognetivity Neurosciences Ltd
CNSX:CGN

Watchlist Manager
Cognetivity Neurosciences Ltd
CNSX:CGN
Watchlist
Price: 0.01 CAD Market Closed
Market Cap: CA$885.9k

Net Margin

-8 730.2%
Current
Improving
by 4 624%
vs 3-y average of -13 354.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8 730.2%
=
Net Income
CA$-8.6m
/
Revenue
CA$99k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8 730.2%
=
Net Income
CA$-8.6m
/
Revenue
CA$99k

Peer Comparison

Country Company Market Cap Net
Margin
CA
Cognetivity Neurosciences Ltd
CNSX:CGN
895.6k CAD
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.4B USD
Loading...
US
Gartner Inc
NYSE:IT
16.8B USD
Loading...
IE
ICON PLC
NASDAQ:ICLR
14.5B USD
Loading...
US
Ionis Pharmaceuticals Inc
NASDAQ:IONS
13.3B USD
Loading...
US
Charles River Laboratories International Inc
NYSE:CRL
10.9B USD
Loading...
US
Halozyme Therapeutics Inc
NASDAQ:HALO
8.3B USD
Loading...
US
Cytokinetics Inc
NASDAQ:CYTK
7.7B USD
Loading...
UK
Verona Pharma PLC
NASDAQ:VRNA
7.4B USD
Loading...

Market Distribution

Lower than 95% of companies in Canada
Percentile
5th
Based on 4 909 companies
5th percentile
-8 730.2%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Cognetivity Neurosciences Ltd
Glance View

Market Cap
885.9k CAD
Industry
N/A

Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-03-19. The firm is engaged in developing a cognitive testing platform, the integrated cognitive assessment (ICA), for use in medical and commercial environments for allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from early detection of cognitive impairment in dementia and multiple sclerosis (MS), to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The firm serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.

CGN Intrinsic Value
Not Available
C
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-8 730.2%
=
Net Income
CA$-8.6m
/
Revenue
CA$99k
What is Cognetivity Neurosciences Ltd's current Net Margin?

The current Net Margin for Cognetivity Neurosciences Ltd is -8 730.2%, which is above its 3-year median of -13 354.2%.

How has Net Margin changed over time?

Over the last 10 months, Cognetivity Neurosciences Ltd’s Net Margin has increased from -16 374% to -8 730.2%. During this period, it reached a low of -16 374% on Jan 31, 2023 and a high of -8 730.2% on Dec 1, 2023.

Back to Top